High-Throughput Hit Discovery for Ion Channels and G Protein-Coupled Receptors
New approaches for hit discovery against Ion Channels and GPCRs using the Fluorescent Imaging Plate Reader (FLIPR) technology. Ion channels
High-Throughput Hit Discovery for Ion Channels and G Protein-Coupled Receptors
New approaches for hit discovery against Ion Channels and GPCRs using the Fluorescent Imaging Plate Reader (FLIPR) technology. Ion channels
Cost Effective Screening in 384 and 1536 well plates
Discover the advantages of utilizing both 384 and 1536 well plates in high-throughput screening (HTS). Learn how enhanced flexibility, cost-effectiveness, and adaptability can optimize your research efforts. Partner with us for streamlined data management and a competitive edge in drug discovery.
Delia I. Fernández, Sara Troitiño, Vladimír Sobota, Bibian M. E. Tullemans, Jinmi Zou, Helma van den Hurk, Ángel García, Saman Honarnejad, Marijke J. E. Kuijpers & Johan W. M.
Label-Based and Label-Free Assays in Drug Discovery
Dive into the world of label-based and label-free assays with Pivot Park Screening Centre. Understand their pivotal role in drug discovery and how choosing the right partner can make all the difference.
Pivot Park Screening Centre (PPSC) has adopted Affinity Selection Mass Spectrometry (ASMS) workflow into its daily high-throughput screening (HTS) operations.
Exploring the world of early drug discovery through business travel
This blog delves into the world of business travel, specifically within the context of drug discovery, unraveling the intricacies of cultural nuances, the significance of personal interactions, and the divergent business cultures of the Dutch and the Japanese.
Hit-to-lead optimization: the next step in drug development
Selecting the right partner for your hit-to-lead optimization project is crucial in advancing drug discovery. Key considerations include the partner’s expertise, highly standardized and accurate operations, track record in hit-to-lead optimization, and experience with similar targets or small molecules.
Merry Christmas and a Happy New Year
As the year draws to a close, we want to take a moment to extend our warmest wishes to you.
Exploring the Potential of Small Molecule Compound Libraries in Drug Discovery
In the world of drug discovery, the search for new therapeutic agents that can alleviate suffering and improve the quality of life for millions of people is unending. In small molecule drug discovery, compound libraries form the foundation of these ventures. These libraries are treasure troves of potential drug candidates.
Oncode Investigator Mario van der Stelt (Leiden University) and his team discovered a new potential drug (compound name: LEI-515) that
ABSTRACT Efforts to tackle malaria must continue for a disease that threatens half of the global population. Parasite resistance to
The Crucial Role of Efficient Data Management in Accelerating Drug Discovery
Discover the key role of effective data handling in pharmaceutical research with Pivot Park Screening Centre. Our state-of-the-art automation and screening infrastructure, coupled with ISO certifications and diverse data analysis techniques, ensure secure and quality data. Learn how our multidisciplinary team accelerates drug discovery, making us your trusted partner in early drug discovery efforts.
Subscribe to our newsletter
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands